These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8998713)

  • 1. [Gradual reduction of arterial pressure and 24-hour blood pressure control as objective of antihypertensive therapy].
    Stella ML; Grassi G; Mancia G
    Cardiologia; 1995 Dec; 40(12 Suppl 1):189-91. PubMed ID: 8998713
    [No Abstract]   [Full Text] [Related]  

  • 2. [History of the pharmacologic therapy of arterial hypertension: from diuretics to angiotensin II receptor antagonists].
    Salvetti A; Ghiadoni L; Virdis A
    Cardiologia; 1995 Dec; 40(12 Suppl 1):181-6. PubMed ID: 8998712
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of angiotensin II inhibitors in arterial hypertension: clinical trials and guidelines].
    Mancia G; Grassi G
    Ann Ital Med Int; 2000; 15(1):92-5. PubMed ID: 10842897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonists: enlarging therapeutic possibilities in arterial hypertension.
    Plante GE
    Can J Cardiol; 1999 Nov; 15 Suppl F():4F-6F. PubMed ID: 10579746
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative review of the efficacy of antihypertensive agents on 24 h ambulatory blood pressure.
    Lacourcière Y; Poirier L; Lefebvre J
    Can J Cardiol; 2000 Sep; 16(9):1155-66. PubMed ID: 11021959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of arterial hypertension with angiotensin receptor blockers].
    Nobre FL
    Rev Port Cardiol; 1999 Apr; 18(4):407-12. PubMed ID: 10371849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The therapy of arterial hypertension: a comparison between ACE inhibitors and angiotensin-II-receptor antagonists].
    Rossi F; Mangrella M; Paternò E; Imperatore F; Capristo M; Imperatore C; Guarino A
    Clin Ter; 1996 Oct; 147(10):475-88. PubMed ID: 9264900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe and effective management of hypertension with fixed-dose combination therapy: focus on losartan plus hydrochlorothiazide.
    Benedict CR
    Int J Clin Pract; 2000; 54(1):48-54. PubMed ID: 10750261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic and pharmacodynamic aspects of angiotensin II antagonists. Focus on arterial hypertension].
    da Silva PM
    Rev Port Cardiol; 1998 Jun; 17(6):545-55. PubMed ID: 9677832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
    Rajzer M; Kawecka-Jaszcz K; Wojciechowska W
    Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor antagonists: what future?
    Onuigbo M
    South Med J; 1998 Aug; 91(8):794-6. PubMed ID: 9715233
    [No Abstract]   [Full Text] [Related]  

  • 12. [The first clinical experience in Italy with angiotensin II receptor antagonists: results of a multicenter study on the efficacy and tolerance in arterial hypertension].
    Trimarco B
    Cardiologia; 1995 Dec; 40(12 Suppl 1):193-5. PubMed ID: 8998714
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin II antagonism: a new avenue of hypertension management.
    Gavras H
    Blood Press Suppl; 1997; 1():42-6. PubMed ID: 9285108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-angiotensin system and cardiovascular disease.
    Hollenberg NK
    Blood Press Suppl; 2000; 1():5-8. PubMed ID: 11059628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
    Weir MR
    Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):416-21. PubMed ID: 17693755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring the arterial pressure in the evaluation of antihypertensive therapy].
    Bignotti M
    Minerva Cardioangiol; 1993 Sep; 41(9):383-6. PubMed ID: 8259234
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antihypertensive therapy using a combination of angiotensin 1 receptor inhibitors with angiotensin-converting enzyme inhibitors].
    Meyer GJ
    Dtsch Med Wochenschr; 1998 May; 123(21):681. PubMed ID: 9638097
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination therapy with an angiotensin converting enzyme inhibitor and an angiotensin-II receptor antagonist for refractory essential hypertension.
    Bisognano JD; Horwitz LD
    West J Med; 1998 Apr; 168(4):272-4. PubMed ID: 9584674
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
    Chikhladze NM
    Ter Arkh; 2000; 72(12):67-9. PubMed ID: 11201840
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinico-genetic aspects of the hypotensive response and regression of left ventricular hypertrophy in arterial hypertension patients].
    Moiseev VS; Kotovskaia IuV; Kobalava ZhD; Nosikov VV; Korovina EP; Timofeeva SG
    Ter Arkh; 2002; 74(10):30-7. PubMed ID: 12469628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.